These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 4823533
21. Blocking of syngeneic effector T cells by soluble tumour antigens. Plata F, Levy JP. Nature; 1974 May 17; 249(454):271-4. PubMed ID: 4545403 [No Abstract] [Full Text] [Related]
22. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey). McCoy JL, Ting RC, Morton DL, Law LW. J Natl Cancer Inst; 1972 Feb 17; 48(2):383-91. PubMed ID: 4347035 [No Abstract] [Full Text] [Related]
23. Studies on immunity to autochthonous mouse tumors. Hellström I, Hellström KE, Pierce GE, Fefer A. Transplant Proc; 1969 Mar 17; 1(1):90-4. PubMed ID: 5406848 [No Abstract] [Full Text] [Related]
24. [Antigenic systems of tumors and leukemias induced by oncornaviruses]. Levy JP, Kourilsky FM. Ann Inst Pasteur (Paris); 1972 Apr 17; 122(4):741-53. PubMed ID: 4340545 [No Abstract] [Full Text] [Related]
25. Immunogenicity and enhancement of normal and tumor tissue in the mouse. McKenzie IF, Snell GD. Transplant Proc; 1973 Mar 17; 5(1):953-6. PubMed ID: 4572155 [No Abstract] [Full Text] [Related]
26. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens. Bonavida B. J Immunol; 1974 Mar 17; 112(3):926-34. PubMed ID: 4544178 [No Abstract] [Full Text] [Related]
27. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction. Senik A, Gomard E, Plata F, Levy JP. Int J Cancer; 1973 Jul 15; 12(1):233-41. PubMed ID: 4133585 [No Abstract] [Full Text] [Related]
28. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro. Kieler J, Radzikowski C, Moore J, Ulrich K. J Natl Cancer Inst; 1972 Feb 15; 48(2):393-405. PubMed ID: 4652381 [No Abstract] [Full Text] [Related]
29. Change of cell-mediated cytotoxicity with aging. Shigemoto S, Kishimoto S, Yamamura Y. J Immunol; 1975 Jul 15; 115(1):307-9. PubMed ID: 807628 [No Abstract] [Full Text] [Related]
30. Abrogation of lymphocyte trapping by ascitic tumours. Frost P, Lance EM. Nature; 1973 Nov 09; 246(5428):101-3. PubMed ID: 4585847 [No Abstract] [Full Text] [Related]
33. In vitro and in vivo cytotoxicity to EL-4 sarcoma in New Zealand mice. Gershwin ME, Klingenstein RJ, Chused TM, Steinberg AD. J Immunol; 1974 Dec 09; 113(6):1968-77. PubMed ID: 4279264 [No Abstract] [Full Text] [Related]
34. The effect of histocompatibility antigens on lymphocyte migration in the mouse. Zatz MM, Gingrich R, Lance EM. Immunology; 1972 Nov 09; 23(5):665-75. PubMed ID: 4539074 [Abstract] [Full Text] [Related]
35. The decline of cell-mediated immunity in aging mice. Menon M, Jaroslow RN, Koesterer R. J Gerontol; 1974 Sep 09; 29(5):499-505. PubMed ID: 4212398 [No Abstract] [Full Text] [Related]
36. The H(Tla) histocompatibility locus: a study of in vitro lymphocyte reactivity. Widmer MB, Schendel DJ, Bach FH, Boyse EA. Transplant Proc; 1973 Dec 09; 5(4):1663-7. PubMed ID: 4130073 [No Abstract] [Full Text] [Related]
38. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs. Ellman L, Green I, Benacerraf B. J Immunol; 1971 Aug 09; 107(2):382-8. PubMed ID: 5568769 [No Abstract] [Full Text] [Related]
39. Induced melanoma rejection. Foster M, Herman J, Thomson L, Eitzen L. Yale J Biol Med; 1973 Dec 09; 46(5):655-60. PubMed ID: 4779138 [No Abstract] [Full Text] [Related]